Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-03-24 / Clin. Cancer Res. 2009 Apr;15(7):2531-40Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting
/in Dendritic Cells, International Publications /von 2009-03-11 / Blood 2009 May;113(21):5167-75Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer
/in Dendritic Cells, International Publications /von 2009-02-05 / Vaccine 2009 May;27(25-26):3401-4Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-58Targeting the immune system in cancer
/in Dendritic Cells, International Publications /von 2009-02-01 / Curr Pharm Biotechnol 2009 Feb;10(2):166-84Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway
/in Dendritic Cells, International Publications /von 2009-02-01 / J. Immunol. 2009 Feb;182(3):1449-59Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-02-01 / J. Immunol. 2009 Feb;182(3):1667-73Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity
/in Dendritic Cells, International Publications /von 2009-01-26 / Clin. Dev. Immunol. 2008;2008:106321Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens
/in Dendritic Cells, International Publications /von 2009-01-26 / Blood 2009 Apr;113(18):4213-23
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de